178 related articles for article (PubMed ID: 28251684)
1. Influence of age at diagnosis on the clinical characteristics of Crohn's disease in Korea: Results from the CONNECT study.
Hwang SW; Kim JH; Im JP; Ye BD; Koo HS; Huh KC; Cheon JH; Kim YS; Kim YH; Han DS; Kim WH; Kim JS;
J Gastroenterol Hepatol; 2017 Oct; 32(10):1716-1722. PubMed ID: 28251684
[TBL] [Abstract][Full Text] [Related]
2. Long-term prognosis of crohn's disease and its temporal change between 1981 and 2012: a hospital-based cohort study from Korea.
Park SH; Yang SK; Park SK; Kim JW; Yang DH; Jung KW; Kim KJ; Ye BD; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH
Inflamm Bowel Dis; 2014 Mar; 20(3):488-94. PubMed ID: 24412992
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and long-term prognosis of elderly-onset Crohn's disease.
Song EM; Kim N; Lee SH; Chang K; Hwang SW; Park SH; Yang DH; Byeon JS; Myung SJ; Yang SK; Ye BD
Scand J Gastroenterol; 2018 Apr; 53(4):417-425. PubMed ID: 29457917
[TBL] [Abstract][Full Text] [Related]
4. Thiopurines prevented surgical recurrence in patients with Crohn's disease after intestinal resection: Strategy based on risk stratification.
Guo J; Chen BL; Chen ZH; Luo XP; Qiu Y; Zhang SH; Feng R; He Y; Zeng ZR; Song XM; Ben-Horin S; Mao R; Chen MH
J Gastroenterol Hepatol; 2018 Mar; 33(3):608-614. PubMed ID: 28804920
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic features of Crohn's disease associated with failure of medical treatment.
Moran GW; Dubeau MF; Kaplan GG; Yang H; Seow CH; Fedorak RN; Dieleman LA; Barkema HW; Ghosh S; Panaccione R;
Clin Gastroenterol Hepatol; 2014 Mar; 12(3):434-42.e1. PubMed ID: 23978351
[TBL] [Abstract][Full Text] [Related]
6. Adalimumab versus infliximab in treating post-operative recurrence of Crohn's disease: a national cohort study.
Preda CM; Fulger LE; Negreanu L; Manuc M; Sandra I; Diculescu MM
Rev Esp Enferm Dig; 2016 Oct; 108(10):642-647. PubMed ID: 27651132
[TBL] [Abstract][Full Text] [Related]
7. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
[TBL] [Abstract][Full Text] [Related]
8. Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease.
Safroneeva E; Vavricka SR; Fournier N; Pittet V; Peyrin-Biroulet L; Straumann A; Rogler G; Schoepfer AM;
Aliment Pharmacol Ther; 2015 Oct; 42(8):977-89. PubMed ID: 26271358
[TBL] [Abstract][Full Text] [Related]
9. The impact of timing and duration of thiopurine treatment on first intestinal resection in Crohn's disease: national UK population-based study 1989-2010.
Chatu S; Saxena S; Subramanian V; Curcin V; Yadegarfar G; Gunn L; Majeed A; Pollok RC
Am J Gastroenterol; 2014 Mar; 109(3):409-16. PubMed ID: 24469612
[TBL] [Abstract][Full Text] [Related]
10. Infliximab, Immunomodulators and Treatment Failures in Paediatric and Adolescent Patients with Crohn's Disease: a Nationwide Cohort Study.
Lund K; Larsen MD; Knudsen T; Kjeldsen J; Nielsen RG; Mertz Nørgård B
J Crohns Colitis; 2021 Apr; 15(4):575-582. PubMed ID: 32926166
[TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics and Long-Term Outcomes of Paediatric Crohn's Disease: A Single-Centre Experience.
Kim HJ; Oh SH; Kim DY; Lee HS; Park SH; Yang SK; Kim KM
J Crohns Colitis; 2017 Feb; 11(2):157-164. PubMed ID: 27651220
[TBL] [Abstract][Full Text] [Related]
12. Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease.
Walters TD; Kim MO; Denson LA; Griffiths AM; Dubinsky M; Markowitz J; Baldassano R; Crandall W; Rosh J; Pfefferkorn M; Otley A; Heyman MB; LeLeiko N; Baker S; Guthery SL; Evans J; Ziring D; Kellermayer R; Stephens M; Mack D; Oliva-Hemker M; Patel AS; Kirschner B; Moulton D; Cohen S; Kim S; Liu C; Essers J; Kugathasan S; Hyams JS;
Gastroenterology; 2014 Feb; 146(2):383-91. PubMed ID: 24162032
[TBL] [Abstract][Full Text] [Related]
13. The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery.
Papay P; Reinisch W; Ho E; Gratzer C; Lissner D; Herkner H; Riss S; Dejaco C; Miehsler W; Vogelsang H; Novacek G
Am J Gastroenterol; 2010 May; 105(5):1158-64. PubMed ID: 20010925
[TBL] [Abstract][Full Text] [Related]
14. Comparison of infliximab with adalimumab in 827 biologic-naïve patients with Crohn's disease: a population-based Danish cohort study.
Singh S; Andersen NN; Andersson M; Loftus EV; Jess T
Aliment Pharmacol Ther; 2018 Mar; 47(5):596-604. PubMed ID: 29239001
[TBL] [Abstract][Full Text] [Related]
15. Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study.
Kugathasan S; Denson LA; Walters TD; Kim MO; Marigorta UM; Schirmer M; Mondal K; Liu C; Griffiths A; Noe JD; Crandall WV; Snapper S; Rabizadeh S; Rosh JR; Shapiro JM; Guthery S; Mack DR; Kellermayer R; Kappelman MD; Steiner S; Moulton DE; Keljo D; Cohen S; Oliva-Hemker M; Heyman MB; Otley AR; Baker SS; Evans JS; Kirschner BS; Patel AS; Ziring D; Trapnell BC; Sylvester FA; Stephens MC; Baldassano RN; Markowitz JF; Cho J; Xavier RJ; Huttenhower C; Aronow BJ; Gibson G; Hyams JS; Dubinsky MC
Lancet; 2017 Apr; 389(10080):1710-1718. PubMed ID: 28259484
[TBL] [Abstract][Full Text] [Related]
16. Clinical Characteristics of Korean Patients with Elderly-Onset Crohn's Disease: Results from the Prospective CONNECT Study.
Kim YS; Na MJ; Ye BD; Cheon JH; Im JP; Kim JS;
Gut Liver; 2022 Nov; 16(6):995-1000. PubMed ID: 36379905
[TBL] [Abstract][Full Text] [Related]
17. Colonic Crohn's Disease Is Associated with Less Aggressive Disease Course Than Ileal or Ileocolonic Disease.
Arora U; Kedia S; Garg P; Bopanna S; Jain S; Yadav DP; Goyal S; Gupta V; Sahni P; Pal S; Dash NR; Madhusudhan KS; Sharma R; Makharia G; Ahuja V
Dig Dis Sci; 2018 Jun; 63(6):1592-1599. PubMed ID: 29611078
[TBL] [Abstract][Full Text] [Related]
18. Crohn's disease prognosis and early immunomodulator therapy: Results from the CONNECT study.
Kim B; Cheon JH; Moon HJ; Park YR; Ye BD; Yang SK; Seo GS; Jang BI; Kim YS; Kim JS; Han DS; Kim YH; Kim WH
J Gastroenterol Hepatol; 2016 Jan; 31(1):126-32. PubMed ID: 26406334
[TBL] [Abstract][Full Text] [Related]
19. Early use of thiopurines or methotrexate reduces major abdominal and perianal surgery in Crohn's disease.
Kariyawasam VC; Selinger CP; Katelaris PH; Jones DB; McDonald C; Barr G; Chapman G; Colliwshaw J; Lunney PC; Middleton K; Wang RR; Huang T; Andrews J; Leong RW
Inflamm Bowel Dis; 2014 Aug; 20(8):1382-90. PubMed ID: 24991785
[TBL] [Abstract][Full Text] [Related]
20. Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates.
Ramadas AV; Gunesh S; Thomas GA; Williams GT; Hawthorne AB
Gut; 2010 Sep; 59(9):1200-6. PubMed ID: 20650924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
